A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 8/18/2010

Posted by | 10:00pm on Wednesday, August 18, 2010

:
Welcome to the marketing & social media pharma chat (#SocPharm). Let’s start w/intros – tell us why you are interested in this topic.

:
I’m Eileen, work at Siren Interactive, relationship marketing for #raredisease therapies. Passionate about interactive. #socpharm

:
As always, we?ll assume that all tweets within #SocPharm are your own and not your employers (unless you specifically declare them).

:
Mark working in the intersection of strategic development in adult learning, MD edu, and HC communications to change outcomes #socpharm

:
@ hi #socpharm! Lexie @ Ketchum. I ? the hinternetz, smart MDs, + helping ppl feel better + find community

:
Hello everyone #socpharm! Angela Dunn here #socpharm

:
@ from Novo Nordisk here! #socpharm

:
I’ll wait a bit to talk about @ social media guidelines because @ said he’d try to jump in but may be late. #socpharm

:
T1: Lilly CEO vows medical innovation in full page local newspaper ad: http://bit.ly/aFQKhbMeaningful? Good use of money? #socpharm

:
What is Q2 for this evening while we are waiting? #socpharm

:
T1 It is financial PR to help drive stock prices #socpharm

:
T1: Bet the recently laid off employees didn’t take too kindly to it. #socpharm

:
T1: I agree with @. Its also send a good signal to employees from outside. Ups the ante. #socpharm

:
T1: If I were recently laid off, I’d be thinking about how I could consult with them to help them nail that innovation. #socpharm

:
@ LOL #socpharm

:
T1: For better or worse, no one is owed a job, only an opp to add value, and hopefully that generates income. :-) #socpharm

:
T2: Roche publically releases sm guidelines. Link to PDF at start of article: http://bit.ly/aEfeTt. What do we think? #socpharm

:
So can someone tell me what the significance of the Roche publication is? I am missing something here. #socpharm

:
T2: Reference to “be a scout” for AEs was interesting. States it’s employees responsibility to be aware for identifiable AEs. #socpharm

:
@ @ Most significant is asking all employees to be “scouts” & report back anything they hear + or – #socpharm

:
@ Think this is the first time that pharmaco has publically released their sm guidelines. #socpharm

:
T2: For those outside pharmaco these internal docs have been shrouded in secrecy. Refreshing to see transparency. #socpharm

:
@ it is not significant. It is a way to say here are our rules of engagement sets limits #socpharm

:
Why is the scouting and publishing of SM policy publicly “significant”? Forgive my obtuseness here. #socpharm

:
There are whole blogs of these policies. They are in fact not shrouded in secrecy at all. #socpharm

:
@ Pharma social media policies? Can you point me in the direction of those links? #socpharm

:
Why do they need to be pharma social media policies? They are corporate social media policies. Hold on. #socpharm

:
Policies here: http://www.delicious.com/search?p=social+policy&chk=&context=userposts|skoko|guidelines+Roche&fr=del_icio_us&lc= #socpharm

:
@ Because pharma feels more comfortable following other pharmacos. And the regulated environment including AEs. #socpharm

:
These guidelines really help Roche to define how 10,000 employees behave online. That is good with that much DNA in your employ #socpharm

:
Let’s try this social media policy thing again: http://ht.ly/2rC54 #socpharm

:
@ Not saying it makes sense! #socpharm

:
So by scouting are they asking their employees to actively search for AEs on the internet? #socpharm

:
@ U might be looking 4 these although @ is the only pharma here http://socialmediagovernance.com/policies.php #socpharm

:
Hi, joining late, I think it shows best-practice leadership in laying proper governance foundation for new media activities #SocPharm

:
Thanks @! I will deliciousmark that. #socpharm

:
@ Doc states “Be a scout 4 sentiment & critical issues” & “u are one of our most vital assets 4 monitoring sm landscape” #socpharm

:
@ My pleasure! :) #socpharm

:
What the new #Facebook geolocation tool could mean (via @) http://bit.ly/d6DpVQ #socpharm

:
@ I agree, well said #socpharm

:
@ thanks. #SocPharm

:
Thanks @. I see they do not mean AEs. @, I’d say let keep watching for whether this is a best practice. #socpharm

:
T3: @ launched a new social network for people with cystic fibrosis: http://bit.ly/958siF Has anyone checked it out yet? #socpharm

:
RT @ …think it shows best-practice leadership in laying proper governance foundation for new media activities #socpharm

:
I’d be interested to see how they capture, filter & benefit from results of their employee scouting. Now that will b innovation! #socpharm

:
@ I also like that @ sm guidelines were in easy to read language & used common sense! #socpharm

:
T2 one more comment – you don’t have 2 totally agree, but puts stake in ground and is an example for others by transparent #SocPharm

:
@ very good point #SocPharm

:
A great tool for internal & external social media collaboration for Twitter & Facebook is @: @ #socpharm

:
@ We’ll have to follow-up with @ on how @ is able to benefit from results of employee “scouting” #socpharm

:
I will give u that its a stake in ground. I just wonder if sometime we are too eager to make news out of every SM twitch we see. #socpharm

:
@ haven’t looked at Novartis site in depth but has that popular patient-centric community focus but branded #SocPharm

:
@ Hello Eva! Nice to see you, enjoyed your post, too, on @‘s list! #socpharm

:
@ Come on, I live for this stuff!! Pharma blinks about sm & we tweet :) #socpharm

:
…but all good things get tiresome after a while. SM is here to stay. What’s the new new thing? #socpharm

:
T3: Like the way @ CF site uses map for users, but I’m not sure it’s truly a social network. Another CF comm needed? #socpharm

:
@ I think the new think is location-based services http://bit.ly/dlfMR2 As you know, I love @ #socpharm

:
@ Glad U could join us! #socpharm is always a good chat! Think @ could use @ for new process 4 ‘scouts’!

:
CFConnection looks to be a nice “participation space” for the CF community. Nice to see things moving in this direction. #socpharm

:
I agree @. FourSquare is my new thing and esp since I discovered the special offers. Has lots of potential for pharma! #socpharm

:
In the last few minutes tonight, anyone have any upcoming events we should know about? Any particularly interesting blogs? #socpharm

:
@: @ intrstng b/c any1 can send tweet via SMS even customers & U have editorial control & option 2 go offline #socpharm

:
@ Looks like Facebook just announced their take on Foursquare check ins http://tcrn.ch/de30vm #socpharm

:
I will shamelessly promote my blog, www.wiseworking.com, if you like reads about, well, wise working. :-) #socpharm

:
@ We love shameless self-promotion and wisdom :) #socpharm

:
Yeah @, I already send @ to the SM team at my gig. #socpharm

:
Sorry I missed the fun. I’m @ a dinner & couldn’t get away. #socpharm

:
CER is hot topic and many industry events…a new site to compare Prostate therapy choices was annouced this week… #SocPharm

:
Based on last year, I’m excited about @ ePatient Connections event in Philly in Sept http://bit.ly/b79ekK #epatcon #socpharm

:
@ Interesting! Are they using @? #socpharm

:
You can also just follow the tweets at @. I forgot about that. Hmmm. #socpharm

:
@ Better late than never! What’s the internal take at @ about the SM guidelines? #socpharm

:
RT @: Based on last year, excited about @ ePatient Connections in Philly Sept http://bit.ly/b79ekK #epatcon #socpharm

:
@ What is CER? Got link to prostate choice site? #socpharm

:
I will provide later… Comparative/cost effectiveness research #SocPharm

:
@ No @ yet and time will tell if we start using it. :-) Thanks for tip. #socpharm

:
Thanks @! #socpharm

:
@ @ THX for “CER” another one for our list! http://bit.ly/dkjQ4l #socpharm

:
@ It’s prob late 4 you but #socpharm chat is every Wed 8 pm EST. Last Wed of each quarter (Sep 29) we do it in morning: 8 am EST.

:
List of Pfizer on YouTube, Facebook, Twitter, SlideShare, LinkedIn, & blogs via @@pfizer_news http://bit.ly/d6Ct6A #socpharm

:
Well, time is up. Thanks everyone for joining in #socpharm. Please let me know if you have any topics/questions for next week.

:
RT @: CER is hot topic and many industry events…a new site to compare Prostate therapy choices was annouced this week… #SocPharm

:
@ woops I totally missed #socpharm discussion! Got a last minute invite to #Google — which I don’t ever refuse! Catch up later!

:
@ @ good, positive direction. More external attn than internal. #socpharm

:
@ @ @ @ @ Thank you for the convo, have a nice evening! #socpharm

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com